This translational research aimed to investigate the clinical significance of the immune microenvironment of TNBC in association with HRD, tumor BRCA1/2 (tBRCA1/2) mutation, and response to NAC in order to give further insights in TNBC biology including tumor microenvironment for the improvement of treatment strategies of TNBC. Here, BRCA1 is linked to neoplasm.